Current NICE guidance does not recommend glutathione supplementation for non-alcoholic fatty liver disease (NAFLD) and it is not part of standard NHS treatment protocols

IHADA TONE UP UV: Tranexamic acid*, purified water, octamethyltrisiloxane, 2-ethylhexyl p-methoxycinnamate, decamethyltetrasiloxane, dipropylene glycol, methylphenylpolysiloxane, glyceryl tri-2-ethylhexanoate, silicic anhydride, 1,3-butylene glycol, PEG-9 polydimethylsiloxyethyl Dimethicone, concentrated glycerin, phenylbenzimidazole sulfonic acid, sorbitan sesquiisostearate, stearic acid, triethanolamine, aluminum hydroxide, trehalose, polypropylene glycol, isostearic acid, glyceryl triisostearate, 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoic acid hexyl ester, dimethyl distearyl ammonium hectorite, methylpolysiloxane, chlorphenesin, trisodium edetate, dl--tocopherol, dibutyl hydroxytoluene, tetrahydrotetramethylcyclotetrasiloxane, witch hazel extract, sodium metabisulfite, tetradecene, petrolatum, L-theanine, phenoxyethanol, fine titanium dioxide, titanium dioxide, yellow iron oxide, red iron oxide, yellow iron oxide-coated titanium mica * indicates active

For instance, disruptions in cholinergic signaling are linked to cognitive impairments, while alterations in GABAergic and glutamatergic transmission contribute to motor dysfunction and excitotoxicity, respectively (Obeso et al., 2017)
10.1096/fj.201801116RR 161 YuY.ZhaoW.ZhuC.KongZ.XuY.LiuG.et al (2015)